ABVC BioPharma inks licensing agreement with OncoX; expecting aggregate income of $13.75 mn and royalties of up to $12.50 mn

6d ago, source: Pharmabiz

Fremont, California Friday, April 19, 2024, 14:00 Hrs [IST] ...

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

7d ago, source:

FREMONT, CA, April 18, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — (NASDAQ: ABVC) ("Company"), a clinical-stage ...

ABVC BioPharma Enters Licensing Agreement With OncoX For Commercialization Of BLEX 404

8d ago, source:

ABVC BioPharma, Inc. (ABVC) announced the company, together with its affiliate Rgene Corporation entered into a licensing agreement ...

Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

on MSN ago, source:

Tesla shares jumped 10.6% to $160.01 in pre-market trading. Here are some other stocks moving in pre-market trading. Chicken ...

Deal watch: Biopharma M&A more than doubled in Q1

3d ago, source:

Mergers and acquisitions are on the rise in 2024, sending a hopeful sign for the recovery of the life sciences market. Check ...

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

1d ago, source:

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, announced today that ...

Phase II miss in PD cognitive impairment clips Sage

8d ago, source: BioWorld

Sage Therapeutics Inc. shares (NASDAQ:SAGE) were trading at $12.52, down $3.11, or almost 20%, after the Cambridge, Mass.-based firm rolled out top-line data from Precedent, a double-blind, ...

ABVC BioPharma, Inc.: AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

7d ago, source:

FREMONT, CA, April 18, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophth ...